Health Care/Hospital
Alteogen's Tergase® (Novel Recombinant Human Hyaluronidase Injection) Shows Excellent Immunogenicity Profile
Alteogen expects Tergase® will replace commercially available animal-derived hyaluronidase products and their significant disadvantages. Compared with other commercially available hyaluronidase products, Tergase® showed no incidence of anti-drug antibodies (ADA). The occurrence of ADA is known ...
2023-09-05 20:00
1296
David Topper Joined Inmagene as CFO
SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a clinical stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory diseases, today announced the appointment ofDavid Topper as Chief Financial Officer (C...
2023-09-05 20:00
1616
I-Mab Announces Upcoming Participation at September Conferences
ROCKVILLE, Md. and SHANGHAI, Sept. 5, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), is a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies an...
2023-09-05 20:00
1419
Baird Medical's Single-Use Sterile Biopsy Needle Receives Approval from Jiangsu Medical Products Administration in China
GUANGZHOU, China, Sept. 5, 2023 /PRNewswire/ -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, today announced that its subsidiary, Nanjing Changcheng Medical Equipment Co., Ltd., h...
2023-09-05 17:00
1280
Discover the Legumes From Europe project. Which legumes have the highest amounts of protein and why you should make them part of your diet.
SYDNEY, Sept. 5, 2023 /PRNewswire/ -- Encouraging the consumption of legumes is one of the objectives of theLegumes from Europe campaign led by ANICAV – the National Association of Canned Vegetable Industries – and co-funded by the European Union to promote a healthier and more active lifestyle, ...
2023-09-05 15:00
1561
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
* Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform * ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging early immunogenicity data * ACM is in partnering d...
2023-09-05 14:00
1559
Signia Introduces Hearing Aids That Tackle the Most Difficult Challenge for People With Hearing Loss: Group Conversations in Noise
LYNGE, Denmark, Sept. 5, 2023 /PRNewswire/ -- Hearing aid innovator Signia, part of WS Audiology, today launchesIntegrated Xperience, a breakthrough technology that enables hearing aid wearers to hear all speakers in noisy group conversations clearly. Even when speakers move or the wearer turns t...
2023-09-05 14:00
1238
GCCL to be the first in the industry sector to adopt Lab Information Management System (LIMS)
* The first clinical trial sample analysis provider to adopt LIMS * To provide enhanced quality of pharmacokinetic, pharmacodynamic, and immunogenicity data from bioanalytic testing YONGIN, South Korea, Sept. 4, 2023 /PRNewswire/ -- GCCL, a Korean clinical trial sample analysis company, annou...
2023-09-05 09:57
1345
Game-changing Virtuoso Digital Front Door technology radically rewires healthcare
World-first technology launches to unlock preventative, proactive and predictive healthcare BOSTON, Sept. 4, 2023 /PRNewswire/ -- Global leader in population health, Orion Health, is ushering in the next era of health – moving from institution-centric reactive sick care to people-centered preven...
2023-09-04 21:00
1685
ABM Therapeutics Announces First Patient Dosed in Phase I Study of ABM-1310 in patients with BRAF V600 in Relapsed and Drug Resistant Primary Malignant Brain Tumors
SAN DIEGO, Calif. and SHANGHAI, Sept. 1, 2023 /PRNewswire/ -- ABM Therapeutics, a clinical-stage biopharmaceutical company, today announced that the first patient has been successfully dosed in its multicenter Phase I study of ABM-1310 in patients with relapsed and drug resistant primary malignan...
2023-09-02 00:00
3177
Adicon Holdings Limited (9860.HK): Continuous growth in Core Operations, Consistent Profitability Enhancement
HANGZHOU, China, Sept. 1, 2023 /PRNewswire/ -- Adicon Holdings Limited (the "Company" or "Adicon"), one of the largest independent clinical laboratory (ICL) service providers listed on the Stock Exchange ofHong Kong (SEHK), has released its interim results for the first half of 2023. As a leading...
2023-09-01 21:30
5634
Innovac Therapeutics Completes $18 million Series Pre-A Financing To Fund the Development of Its lead Programs and Manufacturing Capabilities
The funding represents a strong endorsement of Innovac's technology, mission and vision from a range of industry Investors BOSTON, SHANGHAI and HANGZHOU, China, Sept. 1, 2023 /PRNewswire/ -- Innovac Therapeutics, an mRNA therapeutics company, today announced the completion of an $18 million Seri...
2023-09-01 20:08
1695
usmile Revolutionizes Oral Care with the Launch of Y10 Pro Sonic Electric Toothbrush in the United States
Smart Screen, Responsive Brushing, and Smart Gum Care - The Future of Dental Hygiene HONG KONG, Sept. 1, 2023 /PRNewswire/ -- usmile, the oral care brand with the largest market share inAsia, proudly introduces its latest groundbreaking innovation to the American market - theY10 Pro sonic electr...
2023-09-01 19:22
1743
Peijia Medical Announces 2023 Interim Results
HONG KONG , Sept. 1, 2023 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutic and neurointerventional procedural medical device markets, today announced financial results for the six months endedJune 30, 2023 ("the period...
2023-09-01 19:00
4593
Jin Medical (NASDAQ: ZJYL) Expands into the Manufacturing Field of lifestyle Beauty Products, Collaborates in Research and Development of Three Beauty and Body Products, Securing Market Orders
CHANGZHOU, China, Aug. 31, 2023 /PRNewswire/ -- Jin Medical International Ltd. ("the Company" or "JinMed") (NASDAQ: ZJYL) is the world's leading provider of rehabilitation equipment. Recently, JinMed announcedit has expand into the field of manufacturing lifestyle beauty products by establishing ...
2023-08-31 22:37
1537
CANbridge Announces Interim Financial Results and Corporate Updates for the Six Months Ended June 30, 2023
BEIJING and CAMBRIDGE, Mass., Aug. 31, 2023 /PRNewswire/ -- CANbridge Pharmaceuticals, Inc. ("CANbridge," stock code 1228.HK), a global biopharmaceutical company, with a foundation inChina, committed to the research, development and commercialization of transformative therapies for rare diseases...
2023-08-31 15:15
3952
Tycoon Group Announces 2023 Interim Results
The Group's Revenue Hits New Heights Net profit for 1H2023 increased more than 2.8 times YoY Benefited from the Full Resumption of Normal Travel Revenue Continues to Generate Profit in Future Results Highlights * Since the full resumption of normal travel between Hong Kong, Macau and Mainland C...
2023-08-31 13:28
4044
Zylox-Tonbridge's ZENFlow Tiger™ LD PTA Dilatation Catheter Receives ANVISA Marketing Approval
HANGZHOU, China, Aug. 30, 2023 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") announced that its ZENFlow Tiger™ LD PTA Dilatation Catheter (hereinafter referred to as "ZENFlow Tiger™"), a product independently ...
2023-08-31 11:31
1682
LOTTE BIOLOGICS Holds 'ESG Declaration Ceremony'
* Announces Human Rights and Environmental Management Charter Alongside Annual Implementation Strategies within its Mid-to-Long-term ESG Roadmap * Strengthens Eco-friendly Policies, Including Greenhouse Gas Reduction Plans from the Initial Factory Design Stage SEOUL, South Korea, Aug. 30, 20...
2023-08-31 09:00
1761
Jacobio Pharma Announces 2023 Interim Results
BEIJING, SHANGHAI and BOSTON, Aug. 30, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, announced its 2023 interim results. During the period, the company recorded revenue ofRMB 40.3 million even as it continued to accelerate multip...
2023-08-30 21:45
3846
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
7120
